Institut Des Neurosciences De La Timone — Clinical Trial Site

15 Registered trials

12 Currently recruiting

Organisation

Institut Des Neurosciences De La Timone

Location

Marseille, France

Identifier

ORG-100028983

Address

27 Boulevard Jean Moulin, 13005, France

Departments

0224:Neuropédiatrie
13
Cardiology
CEPCM
Département de Cardiologie
Dermatologie et Vénérologie
Epilepsie pédiatrique
Haematological and oncological pediatry
Hématologie et Oncologie Pédiatrique
Medical Oncology
Neurovasculaire
ONCOLOGIE
ONCOLOGY
Radiothérapie

Clinical trials at this site (15)

Search interface

Reperfusion with P2Y12 inhibitors in addition to mechanical thrombectomy for perfusion imaging selected acute stroke patients : a multicentr… Recruiting

2024-516163-88-00 Acute ischemic stroke 11 2024-08-01
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3 Recruiting

2025-521621-33-00 Metastatic Melanoma 6 2026-03-16
A Phase Ib/II first-in-human, multicentre, open-label, multiple ascending dose study of S230815 in paediatric participants with KCNT1-relate… Recruiting

2024-513332-17-00 KCNT1-related Developmental and Epileptic Encephalopath 7 2025-11-19
Interest of post-operative chemotherapy in patients with localized uterine leiomyosarcoma suspected to have a high-risk of relapse based on … Recruiting

2023-506350-21-00 Localized, resected, FIGO stage I (2018 classification) 4 2025-01-06
Randomized Phase II, 2-arm Study of Immunomodulation with Atezolizumab concomitant with High Dose Radiation (SBRT) Versus SBRT Alone in Pati… Recruiting

2024-511313-38-00 Soft Tissue Sarcoma 4 2024-11-17
ARGO Colchicine versus Placebo in Acute Myocarditis Patients to Reduce Late Gadolinium Enhancement Mass on Cardiac Magnetic Resonance and th… Recruiting

2024-514610-13-00 patients suffering from acute myocarditis confirmed on 5 2024-10-04
ERASE PH-COPD Recruiting

2022-500862-93-00 Pulmonary Hypertension 5 2024-02-01
MetroWilms Recruiting

2022-502687-20-00 Wilms tumor 4 2022-09-14
A multicentre trial evaluating the combination of a MEK inhibitor and a PDL1 inhibitor in pediatric and adult patients with locally advance… Recruiting

2024-510712-75-00 advanced / metastatic 9 2020-02-12
A phase I/II trial of TG4050, an individualised gene therapy, in patients with advanced cancer of the head and neck. Recruiting

2023-508561-33-00 Newly diagnosed, stage III or IV amenable to surgery, H 7 2019-12-12
Adjuvant immunotherapy after salvage surgery in head and neck squamous cell carcinoma: phase 2 trial evaluating the efficacy and the toxicit… Recruiting

2024-516810-39-00 Adjuvant therapy after salvage surgery of high risk rec 4 2018-02-13
AcSé-ESMART: European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors Recruiting

2024-514791-40-00 pediatric cancer 9 2016-08-03
Randomized phase 2 trial of two chemotherapy regimens plus or minus bevacizumab in patients with well differentiated pancreatic neuroendocri… Ended

2023-505286-84-00 Pancreatic well differentiated neuroendocrine tumors (N 4 2018-06-25
A two-year, double-blind, randomized, multicenter, active controlled Core Phase study to evaluate the safety and efficacy of fingolimod admi… Ended

2023-507556-68-00 Multiple Sclerosis 5 2013-07-26
A Phase 1/2, Open-Label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Antineoplastic Activity of IPH6501 in Pat… Ended

2023-506976-28-00 Relapsed and/or Refractory CD20-expressing Non-Hodgkin 9 2024-05-16